Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
Hepion Pharmaceuticals(US:HEPA) InvestorPlace·2024-04-22 20:56Hepion Pharmaceuticals宣布停止临床试验 - Hepion Pharmaceuticals宣布计划停止一项临床试验[1] - 该公司正在终止其2b期ASCEND-NASH研究[2] - 由于资源不足，Hepion Pharmaceuticals无法继续试验[3]